SEVIKAR HCT - treatment opportunity for patients with essential hypertension (SeviTarget)

20/11/2012
02/04/2024
EU PAS number:
EUPAS3177
Study
Finalised
Documents
Study protocol
Study results
Study results
English (1.58 MB - PDF) View document
Study report
Other information
Publications